EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Alpha 1,3galactosyltransferase: a target for in vivo genetic manipulation in xenotransplantation


Immunological Reviews 141: 59-70
Alpha 1,3galactosyltransferase: a target for in vivo genetic manipulation in xenotransplantation
This review discusses (1) evidence supporting the view that alpha 1,3galactosyltransferase, which is present in pig cells but is absent in human cells, is responsible for the rejection response by humans against pig tissue transplants, (2) studies on nucleotide sequences of the pig, mouse and cattle alpha 1,3galactosyltransferase gene and the alpha 1,3galactosyltransferase pseudogene in humans, (3) phylogenetic relationships between the alpha 1,3galactosyltransferase sequences of some non-human mammals and sequences for the human A transferase and the human alpha 1,3galactosyltransferase pseudogene, and (4) molecular methods of reducing the expression of the alpha 1,3galactosyltransferase epitope in pigs.


Accession: 002549293

PMID: 7532619



Related references

Pig alpha1, 3galactosyltransferase: a major target for genetic manipulation in xenotransplantation. Frontiers in Bioscience 1: E34-E41, 1996

Regulation of a1,3galactosyltransferase expression in pig endothelial cells. Implication for xenotransplantation. European Journal of Biochemistry 269(5): 64-73, 2002

Manipulation of the anti-alpha-Gal antibody-alpha-Gal epitope system in experimental discordant xenotransplantation. Xenotransplantation 3(1 PART 2): 102-111, 1996

Regulation of alpha1,3galactosyltransferase expression in pig endothelial cells. Implications for xenotransplantation. European Journal of Biochemistry 269(5): 1464-1473, 2002

In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the alpha 1,3galactosyltransferase gene. Cancer Gene Therapy 12(6): 528-539, 2005

The molecular basis for Gal alpha (1,3)Gal expression in animals with a deletion of the alpha 1,3galactosyltransferase gene. Journal of Immunology 176(4): 2448-2454, 2006

Gal alpha(1-3)Gal expression of the cornea in vitro, in vivo and in xenotransplantation. Xenotransplantation 14(6): 612-618, 2007

Synthesis of alpha-gal epitopes on influenza virus vaccines, by recombinant alpha 1,3galactosyltransferase, enables the formation of immune complexes with the natural anti-Gal antibody. Vaccine 15(11): 1174-1182, 1997

Evolution of alpha 1,3galactosyltransferase and of the alpha-Gal epitope. Sub-Cellular Biochemistry 32: 1-23, 1999

Generation of alpha 1,3galactosyltransferase deficient mice. Sub-Cellular Biochemistry 32: 259-279, 1999